Skip to main content

Articles

FDA Approvals
The Hematologic Drug Pipeline: Exciting New Treatment Options Looming
Read More
FDA Approvals
Midostaurin the First Targeted Therapy to Improve Survival in AML: Potentially Practice-Changing
Read More
FDA Approvals
Venetoclax Shows Strong Activity in CLL
Read More
Value-Based Care Must Be Linked to Improved Clinical Outcomes
Read More
Appendix
Read More
The Institute for Clinical and Economic Review and Its Growing Influence on the US Healthcare
Read More
The Economics of Medicare Accountable Care Organizations
Stakeholder Perspective
Time to Reexamine Accountable Care Organizations?
Read More
Comparison of Treatment Costs for Breast Cancer, by Tumor Stage and Type of Service
Stakeholder Perspective
An Ounce of Prevention Is Not a Choice a Patient Gets to Make for Late-Stage Cancer
Read More
Payer Perspectives on PCSK9 Inhibitors
Read More
Top Healthcare Market Trends in 2016
Read More
Page 119 of 245
Results 1181 - 1190 of 2441